BR9808564A - Método de tratar um paciente tendo infecções por hiv - Google Patents

Método de tratar um paciente tendo infecções por hiv

Info

Publication number
BR9808564A
BR9808564A BR9808564-6A BR9808564A BR9808564A BR 9808564 A BR9808564 A BR 9808564A BR 9808564 A BR9808564 A BR 9808564A BR 9808564 A BR9808564 A BR 9808564A
Authority
BR
Brazil
Prior art keywords
treating
hiv infections
patient
hiv
aids
Prior art date
Application number
BR9808564-6A
Other languages
English (en)
Inventor
Shalom Z Hirschman
Original Assignee
Advanced Viral Res Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Viral Res Corp filed Critical Advanced Viral Res Corp
Publication of BR9808564A publication Critical patent/BR9808564A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

<B>MéTODO DE TRATAR UM PACIENTE TENDO INFECçõES POR HIV<D> A presente invenção revela um método de tratar pacientes tendo AIDS ou infecções por HIV pela administração parenteral do produto R, uma preparação de ácido nucléico-peptídeo, em uma combinação com um ou mais agentes antivirais úteis para tratamento de AIDS ou infecções por HIV incluindo inibidores de protease HIV e análogos de nuclosídeo.
BR9808564-6A 1997-04-15 1998-04-15 Método de tratar um paciente tendo infecções por hiv BR9808564A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US83964997A 1997-04-15 1997-04-15
US92288897A 1997-09-03 1997-09-03
PCT/US1998/007481 WO1998046241A1 (en) 1997-04-15 1998-04-15 A combination therapy for hiv infections

Publications (1)

Publication Number Publication Date
BR9808564A true BR9808564A (pt) 2000-05-23

Family

ID=27126131

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9808564-6A BR9808564A (pt) 1997-04-15 1998-04-15 Método de tratar um paciente tendo infecções por hiv

Country Status (12)

Country Link
US (1) US6696422B2 (pt)
EP (2) EP1690545B1 (pt)
JP (1) JP2001520657A (pt)
KR (1) KR20010006189A (pt)
CN (1) CN1103221C (pt)
AT (1) ATE383161T1 (pt)
AU (1) AU748594B2 (pt)
BR (1) BR9808564A (pt)
CA (1) CA2285463C (pt)
DE (1) DE69838980D1 (pt)
ES (1) ES2448466T3 (pt)
WO (1) WO1998046241A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6528098B2 (en) 1996-10-22 2003-03-04 Advanced Viral Research Corp. Preparation of a therapeutic composition
US6303153B1 (en) * 1996-10-22 2001-10-16 Advanced Viral Research Corp. Preparation of a therapeutic composition
US20010049351A1 (en) * 1999-02-25 2001-12-06 Shalom Z. Hirschman Method of determining down-regulation of the expression of hiv coreceptor, ccr5 with product r
US6432966B2 (en) * 1999-10-29 2002-08-13 Smithkline Beecham Corporation Antiviral combinations
US20040033244A1 (en) * 2002-05-28 2004-02-19 Advanced Viral Research, Corp. Treatment of cancers of lymphocytic cells with product R
EP1888085B1 (en) * 2005-06-03 2012-08-08 OHR Pharmaceutical, Inc. Methods for providing palliative care with product r
US20090311236A1 (en) * 2008-06-11 2009-12-17 Immune @Work, Inc. Therapeutic Peptide Compositions And Methods Of Making And Using Same
CN101391103B (zh) * 2008-07-31 2013-07-24 张可 一种预防和治疗艾滋病病毒感染的药物组合物
WO2015054549A1 (en) * 2013-10-09 2015-04-16 Qualcomm Incorporated SLAVE IDENTIFIER SCANNING AND HOT-PLUG CAPABILITY OVER CCIe BUS

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5597824A (en) * 1987-11-03 1997-01-28 Abbott Laboratories Analogs of oxetanyl purines and pyrimidines
US5413999A (en) 1991-11-08 1995-05-09 Merck & Co., Inc. HIV protease inhibitors useful for the treatment of AIDS
US5476874A (en) 1994-06-22 1995-12-19 Merck & Co., Inc. New HIV protease inhibitors

Also Published As

Publication number Publication date
EP0988042B1 (en) 2008-01-09
EP0988042A1 (en) 2000-03-29
US6696422B2 (en) 2004-02-24
ES2448466T3 (es) 2014-03-14
EP1690545A2 (en) 2006-08-16
DE69838980D1 (de) 2008-02-21
ATE383161T1 (de) 2008-01-15
KR20010006189A (ko) 2001-01-26
US20010005712A1 (en) 2001-06-28
CA2285463A1 (en) 1998-10-22
EP1690545B1 (en) 2013-11-20
EP1690545A3 (en) 2007-05-09
CN1103221C (zh) 2003-03-19
AU6971298A (en) 1998-11-11
CN1251996A (zh) 2000-05-03
WO1998046241A1 (en) 1998-10-22
AU748594B2 (en) 2002-06-06
EP0988042A4 (en) 2003-05-21
CA2285463C (en) 2005-06-14
JP2001520657A (ja) 2001-10-30

Similar Documents

Publication Publication Date Title
EA200601591A1 (ru) Применение рибонуклеозидных соединений для лечения флавивирусных и пестивирусных инфекций
BRPI0411900A (pt) compostos antivirais e métodos
BR0309581A (pt) Derivados de nucleosìdeo para tratamento de infecção por vìrus de hepatite c
WO2003062255A3 (en) Sugar modified nucleosides as viral replication inhibitors
AP1782A (en) Use of compounds ?-D or ?-L nucleoside for treating hepatitis C virus.
DZ3487A1 (fr) Derives de nucleoside comme inhibiteurs de l&#39;arn polymerase virale d&#39;arn-dependant
BR9811121A (pt) Produto, composição farmacêutica, e uso de um produto
AU2001289438A1 (en) Pharmaceutical semi-solid composition of isotretinoin
DK1265889T3 (da) Lægemidler imod virussygdomme
CA2224008A1 (en) The treatment of hiv and other viral infections using combinatorial therapy
AU2003291998A8 (en) Method and compositions for identifying anti-hiv therapeutic compounds
BR9907882A (pt) Uso de compostos de 1,5-didesóxi-1,5-imino-d-glucitol n-substituìdos para o tratamento de infecções de vìrus de hepatite
BR9808564A (pt) Método de tratar um paciente tendo infecções por hiv
AU6169298A (en) Use of (n)-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combinationtherapy for treating hepatitis virus infections
BR0317539A (pt) Métodos e composições para o tratamento de infecções por vìrus da herpes usando inibidores seletivos da ou ciclooxigenase-2 ou inibidores da ciclooxigenase-2 em combinação com agentes antivirais
HK1041434A1 (zh) 抗病毒药物和乙型肝炎疫苗的联合
BR0016163A (pt) Tratamento de infecções virais que usa levovirin(r)
FI973184A7 (fi) Kombinaatioterapia HIV-infektiota varten käyttäen HIV-proteaasi-inhibi ittoria indinavir ja käänteistranskriptaasi-inhibiittoria 3TC, mahdoll isesti yhdessä AZT:n, DDI:n tai DDC:n kanssa
BR0212917A (pt) Método para tratamento de infecção de vìrus da hepatite c em pacientes que não responderam a tratamento
DK291390A (da) Terapeutiske anvendelser af 2&#39;,5&#39;-oligoadenylatderivater
AP2000001937A0 (en) Method for identifying chemical active agents and active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway.
WO2004043402A3 (en) Modified nucleosides as antiviral agents
ATE253938T1 (de) Pharmazeutische kombination von antiviralen wirkstoffen
BR0212928A (pt) Processo para tratamento de infecção viral de hapatite c em pacientes que não responderam a tratamento
BR9808873A (pt) Método para tratamento de infecção por papilomavìrus

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: O DEPOSITANTE DEIXOU DE APRESENTAR MANIFESTACAO SOBRE O PARECER NEGATIVO, ASSIM, DE ACORDO COM O ART. 36 DA LPI (LEI 9279/96) 2O, O PEDIDO VOLTA A EXAME SENDO CONSIDERADO NAO PATENTEAVEL PELAS RAZOES EXPOSTAS NO PARECER TECNICO ANTERIOR.